ArticleSynthetic biology (Oxford, England)2017
Tailor-made exopolysaccharides-CRISPR-Cas9 mediated genome editing in
Article in Synthetic biology (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Adenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic.Angewandte Chemie (International ed. in English) · 2026Article
- Synthetic soils for ecological and synthetic biology applications.FEMS microbiology reviews · 2026Review
- Development of a markerless tool for targeted chromosome modification in the thermophilic and methylotrophic bacterium Bacillus methanolicus.Microbial cell factories · 2025Article
- Construction of an efficient electroporation transformation system promotes the application of Targetron in wild-typeApplied and environmental microbiology · 2025Article
- Large genomic, functional, and phenotypical diversity ofFEMS microbes · 2025Article
- CRISPR-Cas9-driven genome editing inFrontiers in microbiology · 2025Article
- Advancing sustainable practices withAIMS microbiology · 2025Review
- Implementation of Spore Display inMicroorganisms · 2024Article
- Engineering the carbon and redox metabolism of Paenibacillus polymyxa for efficient isobutanol production.Microbial biotechnology · 2024Article
- Promising non-model microbial cell factories obtained by genome reduction.Frontiers in bioengineering and biotechnology · 2024Review
- Genome-based analyses to learn from and about Paenibacillus sonchi genomovar Riograndensis SBR5T.Genetics and molecular biology · 2024Article
- Biotechnologically produced chitosans with nonrandom acetylation patterns differ from conventional chitosans in properties and activities.Nature communications · 2022Article
- Insights in the Complex DegU, DegS, and Spo0A Regulation System of Paenibacillus polymyxa by CRISPR-Cas9-Based Targeted Point Mutations.Applied and environmental microbiology · 2022Article
- Analysis of Xylose Operon fromInternational journal of molecular sciences · 2022Article
- Articulating the exuberant intricacies of bacterial exopolysaccharides to purge environmental pollutants.Heliyon · 2021Review
- Effects of an EPS Biosynthesis Gene Cluster ofMicroorganisms · 2021Article
- CRISPR interference-based gene repression in the plant growth promoter Paenibacillus sonchi genomovar Riograndensis SBR5.Applied microbiology and biotechnology · 2020Article
- Inactivation of the Levansucrase Gene in Paenibacillus polymyxa DSM 365 Diminishes Exopolysaccharide Biosynthesis during 2,3-Butanediol Fermentation.Applied and environmental microbiology · 2020Article
- Draft Genome Sequence of Paenibacillus polymyxa DSM 292, a Gram-Positive, Spore-Forming Soil Bacterium with High Biotechnological Potential.Microbiology resource announcements · 2020Article
- Genome analysis of a thermophilic exopolysaccharide-producing bacterium - Geobacillus sp. WSUCF1.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Application of state-of-the-art genome editing tools like CRISPR-Cas9 drastically increase the number of undomesticated micro-organisms amenable to highly efficient and rapid genetic engineering. Adaptation of these tools to new bacterial families can open up entirely new possibilities for these organisms to accelerate as biotechnologically relevant microbial factories, also making new products economically competitive. Here, we report the implementation of a CRISPR-Cas9 based vector system in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.